http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b1970e279988b3a9eeaff34dd127197c
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Dezube |
| name | Bruce J. Dezube Bruce J Dezube |
| given-name | Bruce J Bruce J. |
| organization-name | Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA; and AIDS Malignancy Research and Treatment Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. From the Divisions of Infectious Disease, Experimental Medicine, and Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA. Alexandra M. Levine, City of Hope National Medical Center, Duarte; Erin G. Reid, University of California at San Diego, San Diego; Ronald Mitsuyasu, University of California at Los Angeles Medical Center; Anil Tulpule, University of Southern California Keck School of Medicine, Los Angeles, CA; Ariela Noy, Memorial Sloan-Kettering Cancer Center; Wayne Tam and Ethel Cesarman, Weill Cornell Medical College, New York; Samir Parekh, Montefiore-Einstein Cancer Center, Montefiore Medical Center, Bronx, NY;... Departments of Pathology and Medicine (Hematology-Oncology Division), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 9Millennium Pharmaceuticals, Inc., Cambridge, MA, a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd., Cambridge, Massachusetts. 2Department of Medicine, Harvard Medical School, Boston, Massachusetts.; 4Department of Medicine, Beth Israel Deaconess Medical School, Boston, Massachusetts. 2Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 5The AIDS Malignancy Consortium;; 6Beth Israel Deaconess Medical Center, Boston, Massachusetts; From the Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD; Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR; Division of Hematology/Oncology, University of California–San Francisco, San Francisco, CA; Beth Israel Deaconess Medical Center, Boston, MA; Divisions of Hematologic and of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY; City of Hope, Duarte, CA. Department of Pathology, Beth Israel Deaconess Medical Center, Boston. From the Beth Israel Deaconess Medical Center, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Virginia Mason Cancer Center, Seattle, WA; School of Pharmacy, University of Maryland, Baltimore, MD; and AIDS Malignancy Consortium Operations Center, University of Alabama at Birmingham, Birmingham, AL Henry B. Koon and Zhenghe Wang, Case Comprehensive Cancer Center, Case Western Reserve University; Kord Honda, University Hospitals; Cleveland, OH; Susan E. Krown, Ariela Noy, Memorial Sloan-Kettering Cancer Center, New York, NY; Jeannette Y. Lee, University of Arkansas for Medical Sciences, Little Rock, AR; Suthee Rapisuwon, Georgetown University Medical Center, Washington, DC; David Aboulafia, Virginia Mason Medical Center, Seattle, WA; Erin G. Reid, University of California San Diego Moores Cancer... TUFTS UNIVERSITY; HARVARD MEDICAL SCHOOL Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA Division of Hematology/Oncology Beth Israel Deaconess Medical Center, Harvard Medical School Boston Massachusetts From the Beth Israel Deaconess Medical Center; Boston Medical Center; and Massachusetts General Hospital, Boston, MA; Northwestern University, Chicago, IL; Washington University, St Louis, MO; Memorial Sloan-Kettering Cancer Center, New York, NY; Clinical Pharmacokinetics Section and Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD; and AIDS Malignancy Consortium Operations Center, University of Alabama at Birmingham, Birmingham, AL. 1Beth Israel Deaconess Medical Center;; 4Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; and Takeda Pharmaceuticals International Co. Cambridge MA USA Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, Copyright © 2001 American Society of Clinical Oncology Authors' Affiliations: Departments of1Investigational Cancer Therapeutics (Phase I Clinical Trials Program), 2Leukemia, Division of Cancer Medicine, and 3Hematopathology, and 4Molecular Hematology and Therapy Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; 5Reata Pharmaceuticals, Inc., Irving, Texas; 6Massachusetts General Hospital; 7Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Harvard Medical School; 8Early Drug Development Center, Department of Medical Oncology, Dana-Farber Cancer Institute; 9Dana-Farber Cancer Institute; 10Division of Hematology/Oncology, Massachusetts General Hospital; 11Department of Hematology and Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; and 12Department of Medicine, University Hospitals Case Medical Center, Cleveland, Ohio From the Beth Israel Deaconess Medical Center; PerkinElmer Life Sciences, Boston; Cell Signaling Technology, Beverly, MA; and University of Pittsburgh Cancer Institute, Pittsburgh, PA Department of Clinical Science, TESARO: A GSK Company, Waltham, Massachusetts Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215 Beth Israel Deaconess Medical Center, Boston, MA; TESARO: A GSK Company, Waltham, Massachusetts 7Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited. Departments of Pathology and Medicine, Hematology-Oncology Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA From the Memorial Sloan-Kettering Cancer Center, New York, NY; USC Keck School of Medicine, Norris Cancer Institute, Los Angeles, CA; Massachusetts General Hospital, Harvard Medical School; Beth Israel Deaconess Medical Center, Boston, MA; AMC Operations and Statistical Center, University of Birmingham, Birmingham, AL; University of Washington; Virginia Mason Clinic, Seattle, WA; University of Toronto, Toronto Hospital, Toronto, Ontario, Canada Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA Beth Israel Deaconess Medical Center, Harvard Medical School, Division of Hematology/Oncology, 330 Brookline Ave., Boston, MA 02215, USA. AIDS Malignancy Research and Treatment Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. |
Incoming Links
Showing number of triples: 1 to 201 of 201.